1. Introduction
===============

Diabetic retinopathy (DR) is a common vascular complication of diabetes and constitutes one of the most important causes of vision loss worldwide.^\[[@R1]\]^ Early retinopathy does not have a significant effect on vision, but it can progress to a more advanced stage, termed proliferative diabetic retinopathy (PDR), putting patients at a substantially increased risk of serious visual impairment that can result in permanent vision loss.^\[[@R2]\]^ Therefore, prevention, early detection, and effective management of DR and identification of the determinants for DR progression to PDR are very important to improve public health and ease the financial burden of health care.^\[[@R3]\]^

Besides the common risk factors like chronic hyperglycemia,^\[[@R4]\]^ hypertention,^\[[@R5]\]^ serum lipoprotein,^\[[@R6]\]^ and anemia,^\[[@R7]\]^ diabetes mellitus duration has been recognized as the most important risk factor for the development and progression of DR.^\[[@R8]--[@R11]\]^ Furthermore, some researchers observed a subset of patients with longer diabetes duration, characterized by an early age of onset; these patients' clinical features are significantly different from those of patients with a typical age of onset (middle age or older), with the former subset having a stronger family history, poorer metabolic control, a higher proportion of insulin therapy,^\[[@R12],[@R13]\]^ and a higher risk of premature diabetes-related complications.^\[[@R12],[@R14]--[@R16]\]^ Compared with late-onset diabetes, early-onset diabetes (usually defined as type 2 diabetes mellitus \[T2DM\] that begins before 40 years of age^\[[@R17]\]^) was associated with an increased prevalence of DR^\[[@R18]--[@R20]\]^ and PDR.^\[[@R21],[@R22]\]^ Further study showed that early-onset diabetes increased the risk of DR 1.9-fold, independent of diabetes duration, hemoglobin glycation, blood pressure, and other factors.^\[[@R20]\]^ However, the impact of early age of T2DM diagnosis on the subsequent progression of DR has not yet been carefully examined, particularly the development of sight-threatening PDR. Therefore, in the present study, we explored whether early onset could also affect the risk of developing PDR.

Microalbuminuria is an indicator of generalized endothelial damage^\[[@R23]\]^ and is not only widely accepted as the first clinical sign of diabetic nephropathy but also recognized as a precursor to DR. As microalbuminuria in T2DM patients is related to early signs of diabetic retinopathy, such as decreased retinal microcirculation^\[[@R24]\]^ and inner retinal neurodegeneration,^\[[@R25]\]^ it was not overlooked by clinicians for the early detection of DR.^\[[@R26]\]^ Therefore, we included T2DM patients with microalbuminuria that reflects early diabetic retinal microangiopathy to explore the relationship between early-onset diabetes and the development of PDR. In addition, it is still unclear whether the increased prevalence of complications connected to early-onset diabetes is purely the result of longer disease duration, or on account of the worse metabolic phenotypes, or some inherent factors linked to early-onset diabetes that make tissues more susceptible to hyperglycemic damage. Thus, in the present study, the diabetes duration and other risk factors were adjusted in the model to determine whether early-onset diabetes is an independent risk factor for the development of PDR.

2. Methods
==========

2.1. Subjects
-------------

A total of 461 T2DM patients with microalbuminuria were included from January 1, 2015 to June 25, 2018 in the First Affiliated Hospital of Chongqing Medical University. T2DM was diagnosed based on a standard oral glucose tolerance test (OGTT) or previous medical records. Microalbuminuria was defined at least twice out of 3 times the random urinary microalbumin creatinine ratio (UACR) between 30 and 300 mg/g creatinine. The exclusion criteria were as follows: individuals with age \<18 or \>85 years; type 1 diabetes and other special types of diabetes; definitely diagnosed with other types of chronic renal diseases such as membranous nephropathy or IgA nephropathy; need long-term glucocorticoid treatment for other chronic diseases; and patients with malignant tumor history, immune dysfunction, and severe infection. Subjects were defined as early-onset and late-onset based on the age of diagnosis of diabetes \<40 and ≥40 years, respectively.^\[[@R10],[@R15]\]^ Informed consent was obtained from all participants. This study was approved by the Ethical Committee of the First Affiliated Hospital of Chongqing Medical University.

2.2. Clinical procedures
------------------------

Clinical information regarding family history and medical history was collected through physician interviews. All subjects underwent physical anthropometry measurements, including weight, height, systolic blood pressure (SBP), diastolic blood pressure (DBP), and body mass index (BMI), which was calculated by dividing weight by the height squared. A biochemical analyzer was used to measure plasma glucose levels (BS-380; Mindray Medical International, Shenzhen, China). Glycosylated hemoglobin (HbA1c) was measured using boronate affinity high-performance liquid chromatography (Trinity Biotech, ultra2, Trinity Biotech, Dublin, Ireland). Serum lipids, including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), were measured enzymatically by an automatic analyzer (Model 7080; Hitachi, Tokyo, Japan). Serum creatinine, urinary creatinine, and albumin were measured with an automatic biochemical analyzer (Modular DDP, Roche). UACR was calculated. PDR was defined as at least the following changes based on fundus photography: neovascularization, vitreous hemorrhage, or preretinal hemorrhage.^\[[@R27]\]^

2.3. Statistical analysis
-------------------------

Statistical analysis was performed using the Statistical Package for Social Science, version 22.0 (IBM SPSS, Armonk, NY). Data were expressed as the mean ± standard deviation (SD) when the sample distribution was approximately normal. If normal assumption was not optimal after checking the quantile--quantile plot of the data, we used median (interquartile range, IQR) for expression. Categorical variables were reported as frequencies (percentages). The *χ*^2^ test is used for between-group comparisons. Continuous variables between 2 groups were compared using Student *t* test or the Mann--Whitney *U* test. We conducted Spearman correlation analysis to investigate the risk factors of PDR in T2DM patients with microalbuminuria. Multivariate logistic analysis was conducted to determine whether early-onset diabetes could be an independent risk factor for PDR. Four models were performed to adjust for confounding factors: model 1 was adjusted for gender and T2DM duration; model 2 was further adjusted for other traditional metabolic factors (including SBP, TG, and HbA1c) in addition to the variables in model 1; model 3 was further adjusted for drug factors (including oral hypoglycemic drugs, insulin therapy, antihypertensive drugs, and lipid-lowering drugs) on the basis of model 2. Bilateral *P* values \<.05 were considered statistically significant.

3. Results
==========

3.1. Clinical features of the patients with early-onset and late-onset T2DM
---------------------------------------------------------------------------

The mean age of the 461 T2DM patients with microalbuminuria was 62.4 (SD: 10.9) years, with 11.8 (SD: 7.2) years of duration of diabetes. The clinical characteristics of early-onset and late-onset T2DM are reported in Table [1](#T1){ref-type="table"}. Patients with early-onset diabetes were more likely to be male and younger. The early-onset group had a longer diabetes duration, and a higher DBP and TG were less likely to be on antihypertensive drugs. Compared with subjects with late-onset T2DM, the prevalence of PDR was elevated in patients with early-onset T2DM \[(6.1% vs 1.0%), *P* = .004\].

###### 

Clinical characteristics of patients with early-onset versus late-onset type 2 diabetes.
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3.2. Risk factors of PDR in patients with microalbuminuria
----------------------------------------------------------

According to Spearman correlation analysis (Table [2](#T2){ref-type="table"}), early-onset diabetes (r = 0.135, *P* = .004), oral hypoglycemic drugs (r = −0.101, *P* = .031), and insulin treatment (r = 0.128, *P* = .006) were more correlated with the development of PDR. The factors, such as age, duration of diabetes, and history of hypertension, HbA1c, were not related to the development of PDR in patients with microalbuminuria.

###### 

Spearman correlation coefficient for PRD in patients with microalbuminuria.
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3.3. Early-onset T2DM: an independent factor for PDR in T2DM patients with microalbuminuria
-------------------------------------------------------------------------------------------

Multivariate logistic analysis was conducted to adjust for confounding factors. Model 1 was adjusted for sex and duration of diabetes. Early-onset T2DM patients had a 5.60-fold (95% CI 1.33--23.61) increase in the risk of PDR (Table [3](#T3){ref-type="table"}). Even with further adjustment for other traditional metabolic factors (including SBP, TG, HbAc1), early-onset T2DM still had a marked increased risk of PDR (model 2). Further adjustment for drug factors (including oral hypoglycemic drugs, insulin therapy, antihypertensive drugs, lipid-lowering drugs), early-onset T2DM was associated with a 7.00-fold (95% CI 1.32--37.07) increased risk of PDR in the patients with microalbuminuria (model 3, Table [3](#T3){ref-type="table"}).

###### 

Odds ratio (OR) of early-onset versus late-onset type 2 diabetes for PDR in patients with microalbuminuria.
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4. Discussion
=============

In this study, we demonstrated for the first time that early-onset diabetes increases the risk of PDR in T2DM patients with microalbuminuria. Notably, this finding remains significant after adjusting for diabetes duration and other risk factors, suggesting that early-onset diabetes is an independent risk factor for the development of PDR.

Type 2 diabetes is increasingly diagnosed in children, adolescents, and young adults.^\[[@R28]\]^ Several epidemiological studies have reported a consistent increase in the prevalence of early-onset type 2 diabetes across most regions of the world, for example, in the UK,^\[[@R29]\]^ Finland,^\[[@R30]\]^ and China.^\[[@R31],[@R32]\]^ According to the International Diabetes Federation report, approximately 63 million young adults aged 20 to 39 years had type 2 diabetes worldwide in 2013, which accounted for 16% of total adults with type 2 diabetes.^\[[@R33]\]^

Many patients with early-onset type 2 diabetes develop PDR. A longitudinal observational study showed that of the 1065 early-onset T2DM patients (diabetes diagnosed before 30 years of age), 299 (28%) individuals developed PDR, and nearly half of them developed PDR before the age of 35 years.^\[[@R21]\]^ It was observed in the same cohort that nearly one-third of patients with early-onset diabetes progressed from nonproliferative DR to PDR during a mean follow-up of 7.1 years.^\[[@R22]\]^ The rate of progression from nonproliferative DR to PDR found in patients with early-onset diabetes^\[[@R22]\]^ was considerably higher than that found in late-onset type 2 diabetic patients.^\[[@R34]--[@R36]\]^ These studies suggest that early-onset diabetes may be at high risk for the development of PDR. Our study confirmed that the prevalence of PDR was 6-fold higher in early-onset T2DM patients with microalbuminuria compared with the late-onset phenotype. Of note, we focused on T2DM patients with microalbuminuria, which has been recognized as a marker of generalized endothelial (including retinal microvascular) damage.^\[[@R23]\]^ On the pathological basis of early retinal microangiopathy, the relationship between early-onset diabetes and the development of PDR was identified, and we found that early-onset T2DM had a 7-fold higher risk for PDR compared with the late-onset group, even adjusted for common risk factors.

The mechanisms by which early-onset diabetes increases the risk of PDR have not been fully elucidated. Early-onset diabetes may indicate a longer diabetes duration. Relative to late-onset diabetes, early development of disease imposes a longer exposure to chronic hyperglycemia and increases the likelihood of progression to PDR even before reaching middle age. Notably, our study and other studies have found that early-onset T2DM was still associated with chronic complications even adjusted for diabetes duration.^\[[@R16],[@R20]\]^ This result suggests that there are additional factors hitherto unexplored in early-onset individuals that predispose them to retinopathy. Several studies have observed that early-onset diabetes has a strong family history of diabetes,^\[[@R12]\]^ which may be related to genetic variation. Kong investigated the genetic factors of early-onset T2DM through genetic risk scores (GRSs) and found that early-onset diabetes was associated with genetic variants linked to beta-cell function.^\[[@R37]\]^ One study on the genetic factors of early-onset T2DM through GRSs found that early-onset diabetes was associated with genetic variants linked to beta-cell function. Previous studies have reported that decreased insulin secretion by islet beta cells is a risk factor for severe DR. The prevalence of PDR among those with type 2 diabetes who require insulin was 5 times higher than those who do not.^\[[@R38]\]^ Therefore, we can speculate that the genetic variants linked to beta-cell function in early-onset diabetes lead to a decrease in the insulin secretion ability of beta cells, which further aggravates the progression of DR. In addition, an allele of the (A--C) dinucleotide repeat sequence near the promoter region of the aldose reductase gene appeared in 50% of T2DM patients with DR aged less than 40 years.^\[[@R39]\]^ Conceivably, the genetic factors contributing to early-onset diabetes and its role in the development of vascular complications would be an interesting avenue for future research.

We demonstrated for the first time that early-onset diabetes is an independent risk factor for the development of PDR in T2DM patients with microalbuminuria. With the increased prevalence of early-onset diabetes, our research had important clinical implications: further attention must be paid to the subset of diabetic retinopathy patients with younger diabetes onset, and the metabolic targets applied before middle-age should be made more stringent. The following limitations should be noted. First, our study was a cross-sectional study. Large multicenter prospective cohort studies to explore the cause-effect association between early-onset T2DM and PDR in patients with microalbuminuria are needed in the future. Second, this study was conducted in a single-tertiary hospital center, and some economically disadvantaged patients or patients with mild type 2 diabetes might not have sought medical treatment and thus might have been missed. Third, the precise onset age of T2DM is difficult to determine because of the insidious onset of this disease. The observed onset age may differ from the real onset age.

5. Conclusion
=============

In conclusion, our study provides information on the effect of age at diabetes diagnosis on the development of PDR in patients with microalbuminuria. These perspectives highlight the growing need to direct attention toward early-onset T2DM and to apply effective interventions before middle aged.
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